Analyst Ratings February 5, 2026

Truist Maintains Buy on Crown Holdings After Q4 Beat, Keeps $130 Target

Analyst keeps price objective unchanged as Crown posts stronger-than-expected results but receives mixed market reaction on guidance

By Jordan Park CCK
Truist Maintains Buy on Crown Holdings After Q4 Beat, Keeps $130 Target
CCK

Truist Securities has reaffirmed its Buy rating and $130.00 price target on Crown Holdings (CCK) following the company’s most recent quarterly report. Crown delivered adjusted operating EPS of $1.74, beating Truist and Street estimates and landing at the top of its guidance range, while revenue grew to $3.13 billion. Despite these results, shares ticked down as investors digested the company’s guidance for 2026 and mixed segment performance.

Key Points

  • Truist Securities reaffirmed a Buy rating on Crown Holdings and maintained a $130.00 price target, implying about 13% upside from the then-current price of $115.24.
  • Crown reported adjusted operating EPS of $1.74, beating both Truist's $1.68 estimate and the Street consensus of $1.69, and achieved revenue of $3.13 billion, up 7.7% year-over-year.
  • Valuation metrics cited include a P/E ratio of 14.23 and a free cash flow yield of 8%, while segment results were mixed with beverage divisions outperforming and Asia Pacific, Transit, Other, and Corporate underperforming.

Truist Securities has reiterated its Buy recommendation on Crown Holdings (NYSE: CCK) and kept a $130.00 price target after the packaging company released its latest quarterly results. That target implies roughly 13% upside from the stock's prevailing price of $115.24, with the share price noted as trading close to its 52-week peak of $115.72. Over the past 12 months the stock has returned 36.88%.

The quarter showed stronger-than-expected operating performance on a per-share basis. Crown reported adjusted operating earnings per share of $1.74, topping Truist's $1.68 estimate and the broader Street consensus of $1.69. The result also sat at the high end of Crown's guidance range of $1.65-1.75.

On the top line, the company reported revenue of $3.13 billion for the quarter. That figure exceeded the consensus forecast of $2.99 billion and represented a 7.7% increase versus the same quarter in the prior year.

Third-party data from InvestingPro were cited to show valuation metrics that may underpin Truist's ongoing positive view: a price-to-earnings ratio of 14.23 and a free cash flow yield of 8%.

Performance across Crown's business units was uneven. The Americas Beverage and European Beverage segments outperformed Truist's expectations, while the Asia Pacific, Transit, Other and Corporate segments fell short of what the analyst had projected.

Truist's review of the company's results also highlighted a set of below-the-line items that collectively contributed roughly $0.06 to reported earnings per share. The firm broke these items down as approximately $0.03 from lower income attributable to non-controlling interests, another $0.03 from more favourable interest expense, roughly $0.01 from pension expense, and about $0.01 from a lower share count. These positive adjustments were partially offset by lower interest income, which Truist estimated reduced EPS by approximately $0.01-0.02.

Market response to the earnings and revenue beats was muted. Even with the stronger results, Crown's shares slipped about 1.9% as investors reacted to the company's guidance for 2026, highlighting a divergence between near-term financial outperformance and investor sentiment driven by forward-looking expectations.

Truist's maintained $130.00 target and Buy rating signal the firm's continued conviction in Crown's valuation and cash generation profile, as reflected in the cited P/E and free cash flow yield metrics. At the same time, the report underscores the mixed operational picture across regions and segments and the sensitivity of share price movements to forward guidance.


Context and implications

Investors and analysts will likely monitor how the underperforming segments evolve relative to the company's guidance and whether below-the-line items remain supportive of reported EPS. The combination of a valuation that Truist views as attractive and the mixed segment outcomes frame the firm's decision to keep its Buy rating and $130 target.

Risks

  • Mixed segment performance - underperformance in Asia Pacific, Transit, Other and Corporate segments could pressure future results and affect market sentiment; impacts the industrial and packaging sectors.
  • Investor reaction to forward guidance - despite quarterly beats, shares fell as guidance for 2026 prompted a negative response, showing sensitivity of market valuation to outlooks; impacts equity markets generally.
  • Below-the-line variability - one-time or non-operational items contributed roughly $0.06 to EPS, while lower interest income trimmed results by about $0.01-0.02, indicating earnings may be influenced by financing and accounting items; impacts financial metrics used by investors.

More from Analyst Ratings

Canaccord Lowers Boston Scientific Price Target to $112, Retains Buy Rating Feb 5, 2026 Stifel Lifts Align Technology Target to $210, Cites Strength in Case Volume and Margins Feb 5, 2026 Essex Property Trust guidance falls short of some forecasts as analysts adjust stances Feb 5, 2026 Susquehanna Sticks With Positive View on Uber, Holds $110 Price Target Feb 5, 2026 BTIG Sticks With Buy on Steven Madden, Flags Mixed 2025-26 Outlook Feb 5, 2026